Pharming Group Correlations
| PHGUF Stock | USD 0.75 0.00 0.00% |
The correlation of Pharming Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Pharming Group Correlation With Market
Good diversification
The correlation between Pharming Group NV and DJI is -0.12 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and DJI in the same portfolio, assuming nothing else is changed.
Pharming |
The ability to find closely correlated positions to Pharming Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharming Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharming Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharming Group NV to buy it.
Moving against Pharming Pink Sheet
| 0.5 | QSAM | Qsam Biosciences | PairCorr |
| 0.31 | NVO | Novo Nordisk AS | PairCorr |
| 0.31 | NONOF | Novo Nordisk AS | PairCorr |
| 0.31 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.47 | PG | Procter Gamble | PairCorr |
| 0.43 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Related Correlations Analysis
| 0.08 | 0.16 | -0.04 | 0.17 | GGIFF | ||
| 0.08 | 0.75 | 0.58 | 0.87 | DMPZF | ||
| 0.16 | 0.75 | 0.43 | 0.89 | IGGGF | ||
| -0.04 | 0.58 | 0.43 | 0.53 | PTCHF | ||
| 0.17 | 0.87 | 0.89 | 0.53 | SBMFF | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pharming Pink Sheet performing well and Pharming Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharming Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| GGIFF | 11.40 | 2.37 | 0.07 | (0.68) | 12.08 | 25.00 | 210.00 | |||
| DMPZF | 0.07 | (0.01) | 0.00 | (0.03) | 0.00 | 0.00 | 4.34 | |||
| IGGGF | 2.57 | 1.01 | 0.00 | (5.28) | 0.00 | 7.02 | 56.26 | |||
| PTCHF | 1.83 | 0.04 | 0.00 | 0.17 | 2.19 | 6.07 | 15.48 | |||
| SBMFF | 0.93 | 0.39 | 0.00 | (0.29) | 0.00 | 2.38 | 23.80 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Pharming Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Pharming Group Corporate Management
| Bruno Giannetti | Member of the Management Board, Chief Operations Officer | Profile | |
| Susanne Embleton | Investor Mang | Profile | |
| Jeroen Wakkerman | Chief Officer | Profile | |
| Ruud Outersterp | Chief Officer | Profile | |
| Stephen Toor | Chief Americas | Profile | |
| Anurag Relan | Chief Officer | Profile | |
| MBA MD | CEO Pres | Profile |